Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis

Paused · Phase 2

Conditions studied: Stereotyped Behavior, Mental Retardation

In brief

OBJECTIVES: I. Determine differences between persons with repetitive behavior disorders and matched controls on measures of motor control relevant to basal ganglia pathophysiology. II. Determine the efficacy of bromocriptine, a dopamine agonist, in the treatment of stereotyped behavior and related behavior disorders. III. Determine the efficacy of sertraline hydrochloride, a selective serotonin uptake inhibitor, in the treatment of repetitive behavior disorders. IV. Identify behavioral, environmental, and biological variables with differential drug treatment response.

Key facts

Study ID

NCT00004300

Run by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

People needed

40

Last updated by the study team

2010-10-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Western Carolina Center — Morganton, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.